IPO of Inventrus Knowledge Solutions: The IPO of Inventurus Knowledge Solutions (IKS) opened for subscription on December 12, 2024 and closes on December 16, 2024. The company aims to raise approximately ₹2,497.92 crores through this book-built issue, which includes a fresh issue component and an offer for sale of up to 1.87 crore equity shares of face value ₹1 each.
Inventrus Knowledge Solutions IPO GMP
Adding to the market buzz, the gray market premium (GMP) for IKS IPO is currently up ₹405 per share, indicating an estimated listing gain of 30 percent above the higher price range of ₹1,329. The IPO has received a lot of attention, especially because prominent investor Rekha Jhunjhunwala is backing it.
Inventurus Knowledge Solutions subscription status
The Retail Individual Investors (RIIs) segment was subscribed 4.24 times, while the non-institutional investors category was subscribed 3.13 times. Meanwhile, the allocation for Qualified Institutional Buyers (QIBs) reached an enrollment rate of 1.89 times.
Which GMP, subscription status signal?
The latest gray market premium and subscription trends indicate investor optimism on the issue, and market participants expect the stock to trade at a premium.
Considering the higher price range and the current GMP of the issue, the estimated listing price of the share is ₹1,734, a premium of 30.47 percent.
The current GMP of Inventurus Knowledge Solutions IPO is almost the highest GMP of ₹422, according to market sources.
IPO details of Inventurus Knowledge Solutions
The IPO is priced within a range of ₹1,265 to ₹1,329 per share. The allocation quota is set at 75 percent for Qualified Institutional Buyers (QIB), 15% for High Net-Worth Individuals (HNI) and 10% for retail investors. The shares are expected to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) on December 19, 2024. The allocation is expected to be completed on December 17, 2024.
IKS, a healthcare services provider, reported impressive growth in its financial performance. Revenues rose to ₹1,817.93 crores in FY2024, compared to ₹1,031.30 crores in FY 2023. Similarly, net profit rose from ₹305.23 crores in FY 2023 to ₹370.49 crores in FY2024, underscoring the company’s robust expansion.
The company’s promoters include Sachin Gupta, Rekha Jhunjhunwala, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust and Nishtha Jhunjhunwala Discretionary Trust.
Founded in 2006, Inventurus Knowledge Solutions Limited (IKS Health) specializes in healthcare technology solutions designed to streamline administrative processes for healthcare providers. The company provides a range of services including medical documentation management, virtual medical writing and clinical support. This offer aims to reduce the administrative burden for doctors and healthcare organizations, allowing them to focus more on patient care.
Disclaimer: The above views and recommendations are those of individual analysts, experts and brokerage firms, not of Mint. We advise investors to consult certified experts before making investment decisions.
